Article Figures & Data
Figures
- Fig 1.
Example of CSP and septum pellucidum measurements.
- Fig 2.
Prevalence of MR imaging findings in fighters versus controls.
- Fig 3.
Example of cerebral microhemorrhage in a fighter.
- Fig 4.
Schematic diagram showing the location of all cerebral microhemorrhages observed from all 21 fighters in the study. Although 50 CMHs were observed, 2 fighters had a disproportionate share, and their CMHs have their own symbol of a cross and a triangle. The simplified diagram does not show all the sulci. Most CMHs were actually located near the cortex, and a few were located in the deep white matter.
- Fig 5.
Schematic diagram showing the location of all 15 nonspecific white matter changes observed from 5 randomly selected controls with foci shown by crosses. For comparison of the distribution, 5 randomly selected fighters with NSWMC are shown by circles, which totaled 12. As in Fig 4, the simplified diagram does not show all the sulci, most NSWMCs were actually located near the cortex, and only 2 were located in the periventricular margins.
- Fig 6.
The number of fights in fighters with and without cavum septum pellucidum, cavum vergae, cerebral microhemorrhages, and nonspecific white matter change.
- Fig 7.
Septum pellucidum length, cavum septum pellucidum length, cavum septum pellucidum plus cavum vergae length, and maximum transverse diameter of the CSP in fighters versus controls.
- Fig 8.
Cavum septum pellucidum and cavum septum pellucidum plus cavum vergae to septum pellucidum ratios in fighters versus controls.
